These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38037155)

  • 1. Genome-wide prediction of pathogenic gain- and loss-of-function variants from ensemble learning of a diverse feature set.
    Stein D; Kars ME; Wu Y; Bayrak ÇS; Stenson PD; Cooper DN; Schlessinger A; Itan Y
    Genome Med; 2023 Nov; 15(1):103. PubMed ID: 38037155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of discriminative gene-level and protein-level features associated with pathogenic gain-of-function and loss-of-function variants.
    Sevim Bayrak C; Stein D; Jain A; Chaudhary K; Nadkarni GN; Van Vleck TT; Puel A; Boisson-Dupuis S; Okada S; Stenson PD; Cooper DN; Schlessinger A; Itan Y
    Am J Hum Genet; 2021 Dec; 108(12):2301-2318. PubMed ID: 34762822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VPatho: a deep learning-based two-stage approach for accurate prediction of gain-of-function and loss-of-function variants.
    Ge F; Li C; Iqbal S; Muhammad A; Li F; Thafar MA; Yan Z; Worachartcheewan A; Xu X; Song J; Yu DJ
    Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36528806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing Loss-of-Function and Gain-of-Function
    Hack JB; Horning K; Juroske Short DM; Schreiber JM; Watkins JC; Hammer MF
    Neurol Genet; 2023 Jun; 9(3):e200060. PubMed ID: 37152443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of genomic features in the classification of loss- and gain-of-function mutation.
    Jung S; Lee S; Kim S; Nam H
    BMC Med Inform Decis Mak; 2015; 15 Suppl 1(Suppl 1):S6. PubMed ID: 26043747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting functional effects of missense variants in voltage-gated sodium and calcium channels.
    Heyne HO; Baez-Nieto D; Iqbal S; Palmer DS; Brunklaus A; May P; ; Johannesen KM; Lauxmann S; Lemke JR; Møller RS; Pérez-Palma E; Scholl UI; Syrbe S; Lerche H; Lal D; Campbell AJ; Wang HR; Pan J; Daly MJ
    Sci Transl Med; 2020 Aug; 12(556):. PubMed ID: 32801145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. parSMURF, a high-performance computing tool for the genome-wide detection of pathogenic variants.
    Petrini A; Mesiti M; Schubach M; Frasca M; Danis D; Re M; Grossi G; Cappelletti L; Castrignanò T; Robinson PN; Valentini G
    Gigascience; 2020 May; 9(5):. PubMed ID: 32444882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteome-scale prediction of molecular mechanisms underlying dominant genetic diseases.
    Badonyi M; Marsh JA
    PLoS One; 2024; 19(8):e0307312. PubMed ID: 39172982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human
    Wei AD; Wakenight P; Zwingman TA; Bard AM; Sahai N; Willemsen MH; Schelhaas HJ; Stegmann APA; Verhoeven JS; de Man SA; Wessels MW; Kleefstra T; Shinde DN; Helbig KL; Basinger A; Wagner VF; Rodriguez-Buritica D; Bryant E; Millichap JJ; Millen KJ; Dobyns WB; Ramirez JM; Kalume FK
    J Neurophysiol; 2022 Jul; 128(1):40-61. PubMed ID: 35583973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alanine-scanning mutagenesis of human signal transducer and activator of transcription 1 to estimate loss- or gain-of-function variants.
    Kagawa R; Fujiki R; Tsumura M; Sakata S; Nishimura S; Itan Y; Kong XF; Kato Z; Ohnishi H; Hirata O; Saito S; Ikeda M; El Baghdadi J; Bousfiha A; Fujiwara K; Oleastro M; Yancoski J; Perez L; Danielian S; Ailal F; Takada H; Hara T; Puel A; Boisson-Dupuis S; Bustamante J; Casanova JL; Ohara O; Okada S; Kobayashi M
    J Allergy Clin Immunol; 2017 Jul; 140(1):232-241. PubMed ID: 28011069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When loss-of-function is loss of function: assessing mutational signatures and impact of loss-of-function genetic variants.
    Pagel KA; Pejaver V; Lin GN; Nam HJ; Mort M; Cooper DN; Sebat J; Iakoucheva LM; Mooney SD; Radivojac P
    Bioinformatics; 2017 Jul; 33(14):i389-i398. PubMed ID: 28882004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gain-of-Function Variomics and Multi-omics Network Biology for Precision Medicine.
    Li MM; Awasthi S; Ghosh S; Bisht D; Coban Akdemir ZH; Sheynkman GM; Sahni N; Yi SS
    Methods Mol Biol; 2023; 2660():357-372. PubMed ID: 37191809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAGPIE: accurate pathogenic prediction for multiple variant types using machine learning approach.
    Liu Y; Zhang T; You N; Wu S; Shen N
    Genome Med; 2024 Jan; 16(1):3. PubMed ID: 38185709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variant-specific in vitro neuronal network phenotypes and drug sensitivity in SCN2A developmental and epileptic encephalopathy.
    Jia L; Li M; Pachernegg S; Sedo A; Jancovski N; Burbano LE; Dalby K; Nemiroff A; Reid C; Maljevic S; Petrou S
    J Neurochem; 2024 Dec; 168(12):3950-3961. PubMed ID: 38544375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP2C19 LOF and GOF-Guided Antiplatelet Therapy in Patients with Acute Coronary Syndrome: A Cost-Effectiveness Analysis.
    Jiang M; You JH
    Cardiovasc Drugs Ther; 2017 Feb; 31(1):39-49. PubMed ID: 27924429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Systematic Approach to Assess the Activity and Classification of PCSK9 Variants.
    Uribe KB; Chemello K; Larrea-Sebal A; Benito-Vicente A; Galicia-Garcia U; Bourane S; Jaafar AK; Lambert G; Martín C
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Relevance of Gain- and Loss-of-Function Germline Mutations in STAT1: A Systematic Review.
    Zhang W; Chen X; Gao G; Xing S; Zhou L; Tang X; Zhao X; An Y
    Front Immunol; 2021; 12():654406. PubMed ID: 33777053
    [No Abstract]   [Full Text] [Related]  

  • 18. LoFTK: a framework for fully automated calculation of predicted Loss-of-Function variants and genes.
    Alasiri A; Karczewski KJ; Cole B; Loza BL; Moore JH; van der Laan SW; Asselbergs FW; Keating BJ; van Setten J
    BioData Min; 2023 Feb; 16(1):3. PubMed ID: 36732776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease-specific variant pathogenicity prediction significantly improves variant interpretation in inherited cardiac conditions.
    Zhang X; Walsh R; Whiffin N; Buchan R; Midwinter W; Wilk A; Govind R; Li N; Ahmad M; Mazzarotto F; Roberts A; Theotokis PI; Mazaika E; Allouba M; de Marvao A; Pua CJ; Day SM; Ashley E; Colan SD; Michels M; Pereira AC; Jacoby D; Ho CY; Olivotto I; Gunnarsson GT; Jefferies JL; Semsarian C; Ingles J; O'Regan DP; Aguib Y; Yacoub MH; Cook SA; Barton PJR; Bottolo L; Ware JS
    Genet Med; 2021 Jan; 23(1):69-79. PubMed ID: 33046849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss-of-function, gain-of-function and dominant-negative mutations have profoundly different effects on protein structure.
    Gerasimavicius L; Livesey BJ; Marsh JA
    Nat Commun; 2022 Jul; 13(1):3895. PubMed ID: 35794153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.